Encompass Health (EHC) Cash from Financing Activities (2009 - 2026)

Encompass Health (EHC) has 18 years of Cash from Financing Activities data on file, last reported at -$102.5 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 21.4% year-over-year to -$102.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$403.3 million (up 4.07% YoY) and the FY2025 annual result came in at -$431.2 million, down 30.43% from the prior year.
• Cash from Financing Activities slipped to -$102.5 million in Q1 2026, from -$97.4 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of -$16.5 million in Q4 2022 to a low of -$150.9 million in Q4 2024.
• A 5-year average of -$71.0 million and a median of -$60.9 million in 2022 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 89.65% — and 2024, when it tumbled 404.68%.
• Tracing EHC's Cash from Financing Activities over 5 years: stood at -$16.5 million in 2022, then plunged by 81.21% to -$29.9 million in 2023, then plunged by 404.68% to -$150.9 million in 2024, then jumped by 35.45% to -$97.4 million in 2025, then slipped by 5.24% to -$102.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$102.5 million (Q1 2026), -$97.4 million (Q4 2025), and -$113.2 million (Q3 2025), per Business Quant data.